Well the great thing about the city of London is that it never ceases to amaze!
Vernalis are now being rated as a speculative pharma buy in-house here.
It seems that news is leaking out re’ one of their collaborations/trials, has Ian Garland pulled off a miracle?
You all know my thoughts re’ this Board of robbers.
If they rise will they hit 76p? Doubtful.
Takeover? Anythings possible particulary with Garlands track record.
I think that it may have more to do with the recent regain/buy back of the rights to Frovatriptan which will bring more revenue/income on stream then was at first thought.
The cancer that is endemic to this board may well be in remission but tread carefully a relapse is always on the cards on the not so great ship Vernalis!
We shall see time will tell.